Here, we determined the radiosensitizing properties of monoHER in vitro in breast cancer and normal mammary cells.<h4>Methods</h4>Breast cancer cells with different p53 status (MCF7, wild-type; T47D, mutant) and normal mammary cells (MCF10A) were treated with monoHER and radiation. Here, TP53 is linked to breast carcinoma.